CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong · Delayed Price · Currency is HKD 15.65
+0.17 (1.10%)
Jan 21, 2026, 4:08 PM HKT
HKG:2171 Revenue
CARsgen Therapeutics Holdings had revenue of 50.96M CNY in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 84.05M, up 1,225.65% year-over-year. In the year 2024, CARsgen Therapeutics Holdings had annual revenue of 39.43M.
Revenue (ttm)
84.05M CNY
Revenue Growth
+1,225.65%
P/S Ratio
93.42
Revenue / Employee
226.54K CNY
Employees
371
Market Cap
8.60B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.43M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 25.81M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |